SEOUL, Oct. 13 (Korea Bizwire) — South Korea’s antitrust watchdog said Thursday it has decided to slap a combined 2.6 billion-won (US$1.82 million) fine on global pharmaceutical firm AstraZeneca and local generic maker Alvogen on charges of forging a shady deal to avoid competition. Alvogen suspended its plan to release a generic version of Zoladex, [...]
SEOUL, Aug. 12 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Friday it has tentatively agreed to work with multinational pharmaceutical company AstraZeneca on biopharmaceutical contract manufacturing. The company said in a regulatory filing that it signed a letter of intent on the cooperation in a deal valued [...]
SEOUL, May 24 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, is shutting down its joint venture with multinational pharmaceutical company AstraZeneca Plc., a company official said Tuesday, due to the suspension of the development of a biosimilar product. The move came two months after Samsung Biologics’ board approved [...]
NEW YORK, Feb. 10 (Korea Bizwire) — Nasdaq (Nasdaq: NDAQ) today announced that AstraZeneca PLC – ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. (Nasdaq: XLNX) [...]
SEOUL, Dec. 14 (Korea Bizwire) — British-Swedish pharmaceutical giant AstraZeneca said Tuesday that Samsung Biologics Co., the biotech arm of Samsung Group, will manufacture its antibody combination against COVID-19. Under an agreement valued at approximately US$380 million, Samsung Biologics will manufacture AZD7442 — AstraZeneca’s combination of two long-acting antibodies in development for the potential treatment [...]
SEOUL, Aug. 19 (Korea Bizwire) — Medical experts are divided over the government’s decision to alleviate age requirements for the AstraZeneca’s COVID-19 vaccine, which was originally available only to those over 50 years of age. The Korea Disease Control and Prevention Agency introduced new measures last week that allow citizens over 30 years of age [...]
SEOUL, Aug. 13 (Korea Bizwire) – South Korea on Friday allowed administration of leftover AstraZenenca COVID-19 vaccine doses to people aged 30 and over amid concerns over unused vaccines being wasted, health authorities said. The country had so far only allowed vaccines manufactured by British-Swedish pharmaceutical giant AstraZeneca and Oxford University to people aged 50 [...]
OVERLAND PARK, KS, July 29 (Korea Bizwire) — The findings of DARE-19, a double-blind, placebo-controlled Phase III trial examining Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19, have been published in The Lancet Diabetes & Endocrinology. The study was a collaboration of George Clinical, a global scientifically-backed clinical research organization and Saint Luke’s Mid [...]
SEOUL, May 2 (Korea Bizwire) — South Korea may soon face a shortage of COVID-19 vaccines as less than 10 percent of the country’s AstraZeneca vaccine doses are left, the health authority said Sunday, raising concerns over delays in the nation’s immunization schedule. The nation has secured 2 million AstraZeneca vaccine doses so far, and [...]
SEOUL, April 18 (Korea Bizwire) — South Korea will start giving AstraZeneca’s COVID-19 vaccine to health care workers and airline crews this week to speed up the vaccination drive against the pandemic, the health authority said Sunday. Health authorities will administer AstraZeneca vaccines to health care workers for the disabled, seniors and veterans as well [...]